Biblio Discovery — Demo Discovery Service

17 results for "Jane Skjøth-Rasmussen"

Showing 1–17 · 0.24 seconds · RSS

  1. Journal Article Full text

    Hyperlactatemia associated with elective tumor craniotomy: Protocol for an observational study of pathophysiology and clinical implications.

    Alexandra Vassilieva; Kirsten Møller; Jane Skjøth-Rasmussen et al.

    PLoS ONE, Vol. 17 No. 7 · 2022 · English · DOAJ Scopus

    Hyperlactatemia occurs frequently after brain tumor surgery. Existing studies are scarce and predominantly retrospective, reporting inconsistent associations to new neurological deficits and prolonged hospital stay. Here we describe a protocol for a prospective observational study of…

    Also available at: PLOS

  2. Journal Article

    Orbitopalpebral emphysema in a child after the removal of a giant meningioma: a case report and mini-review

    Ebba Katsler; Anders Tolstrup Christiansen; Annika Reynberg Langkilde et al.

    Brain and Spine, Vol. 5 · 2025 · English · DOAJ Scopus

    Research question: to describe and investigate the case of an 11-year-old boy with the concomitant pneumocephalus, subcutaneous- and orbitopalpebral emphysema after the removal of a giant meningioma. Furthermore, our aim is to discuss the findings and the pathophysiology in relation to cases found…

  3. Journal Article

    Arterial to jugular‐bulb lactate difference in patients undergoing elective brain tumor craniotomy

    Alexandra Vassilieva; Markus Harboe Olsen; Jane Skjøth‐Rasmussen et al.

    Physiological Reports, Vol. 12 No. 20 · 2024 · English · DOAJ Scopus

    Abstract Hyperlactatemia is common during tumor craniotomy, but the underlying pathophysiology is unclear. This study measured simultaneous arterial and jugular‐bulb lactate concentrations in patients undergoing brain tumor craniotomy to investigate the hypothesis that hyperlactatemia was…

  4. Journal Article Full text

    Timing of Early Postoperative MRI following Primary Glioblastoma Surgery—A Retrospective Study of Contrast Enhancements in 311 Patients

    Alexander Malcolm Rykkje; Vibeke Andrée Larsen; Jane Skjøth-Rasmussen et al.

    Diagnostics, Vol. 13 No. 4 · 2023 · English · DOAJ Scopus

    An early postoperative MRI is recommended following Glioblastoma surgery. This retrospective, observational study aimed to investigate the timing of an early postoperative MRI among 311 patients. The patterns of the contrast enhancement (thin linear, thick linear, nodular, and diffuse) and time…

  5. Journal Article

    Laser interstitial thermal therapy for IDH wild-type recurrent glioblastoma: a Scandinavian two-center cohort study

    Silas H. Nielsen; Sara Tabari; Jane Skjøth-Rasmussen et al.

    Acta Neurochirurgica, Vol. 168 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Management of recurrent glioblastoma (rGBM) remains challenging, particularly for deep-seated or eloquent recurrences not amenable to open surgery, and no standardized effective treatment exists for recurrent disease. European data on MR-guided laser interstitial thermal therapy…

  6. Journal Article Full text

    Surgically Induced Contrast Enhancements on Intraoperative and Early Postoperative MRI Following High-Grade Glioma Surgery: A Systematic Review

    Alexander Malcolm Rykkje; Dana Li; Jane Skjøth-Rasmussen et al.

    Diagnostics, Vol. 11 No. 8 · 2021 · English · DOAJ Scopus

    For the radiological assessment of resection of high-grade gliomas, a 72-h diagnostic window is recommended to limit surgically induced contrast enhancements. However, such enhancements may occur earlier than 72 h post-surgery. This systematic review aimed to assess the evidence on the timing of…

  7. Journal Article

    Prospective phase II trial of [68Ga]Ga-NOTA-AE105 uPAR-PET/MRI in patients with primary gliomas: Prognostic value and Implications for uPAR-targeted Radionuclide Therapy

    Aleena Azam; Sorel Kurbegovic; Esben Andreas Carlsen et al.

    EJNMMI Research, Vol. 14 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Background Treatment of patients with low-grade and high-grade gliomas is highly variable due to the large difference in survival expectancy. New non-invasive tools are needed for risk stratification prior to treatment. The urokinase plasminogen activator receptor (uPAR) is expressed in…

  8. Journal Article

    Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study

    Dorte Schou Nørøxe; Aidan Flynn; Christina Westmose Yde et al.

    Molecular Oncology, Vol. 16 No. 1 · 2022 · English · DOAJ Scopus

    Treatment of glioblastoma (GBM) remains a challenging task, with limited treatment options, none offering a cure. Immune therapy has proven effective across different cancers with remarkable response rates. Tumor mutational burden (TMB) is a marker of response, but technical and methodological…

  9. Journal Article

    Prognostic relevance of radiological findings on early postoperative MRI for 187 consecutive glioblastoma patients receiving standard therapy

    Alexander Malcolm Rykkje; Jonathan Frederik Carlsen; Vibeke Andrée Larsen et al.

    Scientific Reports, Vol. 14 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Several prognostic factors are known to influence survival for patients treated with IDH-wildtype glioblastoma, but unknown factors may remain. We aimed to investigate the prognostic implications of early postoperative MRI findings. A total of 187 glioblastoma patients treated with…

  10. Journal Article

    Resolving clonal evolution and selection of extrachromosomal DNA at single-cell resolution

    Josephine Deleuran Hendriksen; Alessio Locallo; Balthasar Clemens Schlotmann et al.

    Genome Biology, Vol. 27 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Genomic alterations are a hallmark of cancer, and extrachromosomal DNA (ecDNA) has emerged as a key source of oncogene selection, tumor growth, and drug resistance. The intratumor heterogeneity and clonal selection of ecDNA is, however, poorly understood. Results In this study…

  11. Journal Article

    Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40

    Camilla Bjørnbak Holst; Ib Jarle Christensen; Jane Skjøth-Rasmussen et al.

    Frontiers in Oncology, Vol. 10 · 2020 · English · DOAJ Scopus

    Background: Complex local and systemic immune dysfunction in glioblastoma (GBM) may affect survival. Interleukin (IL)-6 and YKL-40 are pleiotropic biomarkers present in the tumor microenvironment and involved in immune regulation. We therefore analyzed plasma IL-6, YKL-40, and genetic variation in…

  12. Journal Article

    Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study

    Dorte S. Nørøxe; Christina W. Yde; Olga Østrup et al.

    Molecular Oncology, Vol. 14 No. 11 · 2020 · English · DOAJ Scopus

    Glioblastoma (GBM) is an incurable brain tumor for which new treatment strategies are urgently needed. Next‐generation sequencing of GBM has most often been performed retrospectively and on archival tissue from both diagnostic and relapse surgeries with limited knowledge of clinical information…

  13. Journal Article

    Importance of Comprehensive Molecular Profiling for Clinical Outcome in Children With Recurrent Cancer

    Olga Østrup; Karsten Nysom; David Scheie et al.

    Frontiers in Pediatrics, Vol. 6 · 2018 · English · DOAJ Scopus

    Purpose: Pediatric cancers are often difficult to classify and can be complex to treat. To ensure precise diagnostics and identify relevant treatment targets, we implemented comprehensive molecular profiling of consecutive pediatric patients with cancer relapse. We evaluated the clinical impact of…

  14. Journal Article

    Redefining germline predisposition in children with molecularly characterized ependymoma: a population-based 20-year cohort

    Jon Foss-Skiftesvik; Ulrik Kristoffer Stoltze; Thomas van Overeem Hansen et al.

    Acta Neuropathologica Communications, Vol. 10 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Ependymoma is the second most common malignant brain tumor in children. The etiology is largely unknown and germline DNA sequencing studies focusing on childhood ependymoma are limited. We therefore performed germline whole-genome sequencing on a population-based cohort of children…